CH438343A - Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen - Google Patents
Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinenInfo
- Publication number
- CH438343A CH438343A CH1291863A CH1291863A CH438343A CH 438343 A CH438343 A CH 438343A CH 1291863 A CH1291863 A CH 1291863A CH 1291863 A CH1291863 A CH 1291863A CH 438343 A CH438343 A CH 438343A
- Authority
- CH
- Switzerland
- Prior art keywords
- benzodiazepines
- pyrido
- dihydro
- oxo
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DET0022988 | 1962-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH438343A true CH438343A (de) | 1967-06-30 |
Family
ID=7550793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1291863A CH438343A (de) | 1962-11-08 | 1963-10-21 | Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen |
Country Status (3)
Country | Link |
---|---|
US (1) | US3406168A (de) |
CH (1) | CH438343A (de) |
GB (1) | GB1008172A (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL131929C (de) * | 1966-10-31 | |||
FI50242C (fi) * | 1969-07-18 | 1976-01-12 | Thomae Gmbh Dr K | Menetelmä valmistaa farmakologisesti aktiivisia uusia diallyyliaminoal kanoyylidibenso- tai pyridobenso-diatsepiineja ja niiden happoadditios uoloja. |
AT327200B (de) * | 1972-09-06 | 1976-01-26 | Degussa | Verfahren zur herstellung von neuen aza-10,11-dihydro-5h-dibenzo (b,e)-(1,4) diazepinen sowie deren salzen |
US3976777A (en) * | 1972-12-06 | 1976-08-24 | Smith Kline & French Laboratories, Inc. | Salicylamides and compositions thereof |
GB1400540A (en) * | 1972-12-06 | 1975-07-16 | Smith Kline French Lab | Salicylamides and compositions thereof |
GB2053187A (en) * | 1979-07-09 | 1981-02-04 | Grissmann Chem Ltd | Process for preparing pyrenzepine |
IT1130973B (it) * | 1980-03-17 | 1986-06-18 | Microsules Argentina Sa De S C | Processo per la preparazione di derivati di 5,11-di-idro-6h-pirido(2,3-b) (1,4)-benzodiazepin-6-one,derivati finali ed intermedi di sintesi in tal modo ottenuti |
CA2159815A1 (en) * | 1993-04-05 | 1994-10-13 | R. Tyler Mccabe | M2 receptor ligand for the treatment of neurological disorders |
WO2001055115A1 (en) * | 2000-01-27 | 2001-08-02 | Cytovia, Inc. | Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
US20030134836A1 (en) * | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US7105682B2 (en) * | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
US6995162B2 (en) * | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US7307088B2 (en) * | 2002-07-09 | 2007-12-11 | Amgen Inc. | Substituted anthranilic amide derivatives and methods of use |
CA2573674A1 (en) | 2004-07-16 | 2006-01-26 | Proteosys Ag | Muscarinic antagonists with parp and sir modulating activity as agents for inflammatory diseases |
US8247556B2 (en) * | 2005-10-21 | 2012-08-21 | Amgen Inc. | Method for preparing 6-substituted-7-aza-indoles |
WO2010081823A1 (en) | 2009-01-13 | 2010-07-22 | Proteosys Ag | Pirenzepine as otoprotective agent |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1251767B (de) * | 1964-02-28 | 1968-04-18 | Dr Karl Thomae Gesellschaft mit beschrankter Haftung Biberach/Riß | Verfahren zur Herstellung von neuen m 6 Stellung substituierten 5 6 Dihydro-5oxo HH pyrido[2,3-b] [l,5]benzodiazepinen |
-
1963
- 1963-10-21 CH CH1291863A patent/CH438343A/de unknown
- 1963-11-08 GB GB44251/63A patent/GB1008172A/en not_active Expired
-
1966
- 1966-12-06 US US599385A patent/US3406168A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB1008172A (en) | 1965-10-27 |
US3406168A (en) | 1968-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH412918A (de) | Verfahren zur Herstellung von 1,8-Naphthyridinen | |
CH453340A (de) | Verfahren zur Herstellung von trans-Dimethylolcyclohexan-1,4 | |
CH438343A (de) | Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen | |
CH457473A (de) | Verfahren zur Herstellung von 9,10-Dihydroergovalin | |
CH426830A (de) | Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-derivaten | |
CH430704A (de) | Verfahren zur Herstellung von 4,7-Dihalogen-1-methylindan-3-onen | |
CH408013A (de) | Verfahren zur Herstellung von N-Trichlormethylmercapto-6 H-dibenzo (c,e) (1,2) thiazin-5,5-dioxyden | |
CH481939A (de) | Verfahren zur Herstellung von 4H-Pyrazino-(2,3-d)-(1,3)-oxazin-4-onen | |
CH462178A (de) | Verfahren zur Herstellung von 17a,21-Dihydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolen | |
CH426792A (de) | Verfahren zur Herstellung von 9(11)-Dehydro-12-desoxy-steroiden | |
AT235257B (de) | Verfahren zur Herstellung von Β, Β'-Dicyandiäthyläther | |
CH442306A (de) | Verfahren zur Herstellung von 3,4-Dihydro-benzoxazinonen-(1,3,2) | |
CH439282A (de) | Verfahren zur Herstellung von 11-Keto-5a,9B,10a-19-nor-steroiden | |
CH415651A (de) | Verfahren zur Herstellung von 3-Aryl-4-halogen-pyridazonen-(6) | |
CH475985A (de) | Verfahren zur Herstellung von substituierten 2-Oxo-tetrahydrochinolinen | |
AT231451B (de) | Verfahren zur Herstellung von 2, 6-Diketo-8-thiapurinen | |
CH433355A (de) | Verfahren zur Herstellung von 2,4-Diamino-6-hydroxymethyl-7,8-dihydro-pteridin | |
CH421122A (de) | Verfahren zur Herstellung von 1,3,4-Oxdiazolen | |
CH428769A (de) | Verfahren zur Herstellung von 1,8-Dihydroxyanthrachinonyl-5-thioäthern | |
CH431507A (de) | Verfahren zur Herstellung von 1,2,3,4-Tetrachlor-9-anthron | |
CH489484A (de) | Verfahren zur Herstellung von 16a- bzw. 16B-Hydroxy-17(20)-pregnen-21-säure-y-lactonen | |
CH464184A (de) | Verfahren zur Herstellung von 6B,19B-Oxido-3,5-cyclosteroiden | |
CH444867A (de) | Verfahren zur Herstellung von 3-Azabicyclo-(3,2,2)-nonan-Derivaten | |
AT244938B (de) | Verfahren zur Herstellung von 2, 5-Di-acylamino-3, 6-di-amino-1, 4-benzochinonen | |
CH435313A (de) | Verfahren zur Herstellung von 4-Methyl-6-(2-formyl-propen-1-yl)-pyron-(2) |